This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Cs Pharmaceuticals Limited. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Charles F. Bosworth: Innovator in Ocular Therapeutics
Introduction
Charles F. Bosworth is a notable inventor based in Trabuco Canyon, California. He has made significant contributions to the field of ocular therapeutics, focusing on innovative treatments for ocular diseases. With a total of 2 patents, his work has the potential to improve the quality of life for many individuals suffering from eye-related conditions.
Latest Patents
Bosworth's latest patents include compositions and methods for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface. These pharmaceutical compositions comprise a therapeutically effective amount of a lipophilic compound and a pharmaceutically acceptable carrier. They are specifically designed for peri-ocular transdermal delivery to one or more periorbital glands and/or the ocular surface tissues of a subject. The methods outlined in these patents provide relief from one or more signs or symptoms of ocular diseases. Additionally, they explore the use of Meibomian glands as a drug delivery system for lipophilic compounds, such as steroids, to the ocular surface.
Career Highlights
Charles F. Bosworth is associated with Cs Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing unmet medical needs in the ocular health sector.
Collaborations
Bosworth collaborates with Achim H. Krauss, further enhancing the scope and impact of his research initiatives. Their combined expertise contributes to the development of effective therapeutic solutions.
Conclusion
Charles F. Bosworth stands out as an influential inventor in the field of ocular therapeutics. His innovative patents and dedication to improving ocular health demonstrate his significant contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile